These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9651057)

  • 1. Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy.
    Ng CS; Husband JE; MacVicar AD; Ross P; Cunningham DC
    Clin Radiol; 1998 Jun; 53(6):422-7. PubMed ID: 9651057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CT examination in assessing the response of oesophageal carcinoma to neoadjuvant chemotherapy.
    Krupski W; Pasławski M; Złomaniec J; Ciechański A; Dabrowski A
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):333-7. PubMed ID: 15315010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.
    Melcher AA; Mort D; Maughan TS
    Br J Cancer; 1996 Nov; 74(10):1651-4. PubMed ID: 8932350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography for oesophageal carcinoma: its value to the surgeon.
    Consigliere D; Chua CL; Hui F; Yu CS; Low CH
    J R Coll Surg Edinb; 1992 Apr; 37(2):113-7. PubMed ID: 1377246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of computed tomographic scans in the staging of esophageal and proximal gastric malignancies.
    Maerz LL; Deveney CW; Lopez RR; McConnell DB
    Am J Surg; 1993 May; 165(5):558-60. PubMed ID: 8488936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT evaluation of treatment response in advanced gastric cancer.
    Ng VW; Husband JE; Nicolson VM; Minty I; Bamias A
    Clin Radiol; 1996 Mar; 51(3):215-20. PubMed ID: 8605754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.
    Fareed KR; Al-Attar A; Soomro IN; Kaye PV; Patel J; Lobo DN; Parsons SL; Madhusudan S
    Br J Cancer; 2010 May; 102(11):1600-7. PubMed ID: 20461087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
    Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
    Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loco-regional staging accuracy in oesophageal cancer-How good are we in the modern era?
    Bunting D; Bracey T; Fox B; Berrisford R; Wheatley T; Sanders G
    Eur J Radiol; 2017 Dec; 97():71-75. PubMed ID: 29153370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy.
    Fareed KR; Soomro IN; Hameed K; Arora A; Lobo DN; Parsons SL; Madhusudan S
    World J Gastroenterol; 2012 Apr; 18(16):1915-20. PubMed ID: 22563171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
    Al-Batran SE; Hofheinz RD; Pauligk C; Kopp HG; Haag GM; Luley KB; Meiler J; Homann N; Lorenzen S; Schmalenberg H; Probst S; Koenigsmann M; Egger M; Prasnikar N; Caca K; Trojan J; Martens UM; Block A; Fischbach W; Mahlberg R; Clemens M; Illerhaus G; Zirlik K; Behringer DM; Schmiegel W; Pohl M; Heike M; Ronellenfitsch U; Schuler M; Bechstein WO; Königsrainer A; Gaiser T; Schirmacher P; Hozaeel W; Reichart A; Goetze TO; Sievert M; Jäger E; Mönig S; Tannapfel A
    Lancet Oncol; 2016 Dec; 17(12):1697-1708. PubMed ID: 27776843
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lehmann K; Eshmuminov D; Bauerfeind P; Gubler C; Veit-Haibach P; Weber A; Abdul-Rahman H; Fischer M; Reiner C; Schneider PM
    Eur J Surg Oncol; 2017 Jan; 43(1):196-202. PubMed ID: 27692533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy.
    Mesenas S; Vu C; McStay M; Forshaw M; Doig L; Mason R; Boyle N; Meenan J
    Dis Esophagus; 2008; 21(1):37-42. PubMed ID: 18197937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
    Manoharan V; Lee S; Chong S; Yap J; Coupe N; Wilson R; Merrett N; Ng W; Lin M
    Ann Nucl Med; 2017 May; 31(4):315-323. PubMed ID: 28299585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
    Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
    Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and reproducibility of 3D-CT measurements for early response assessment of chemoradiotherapy in patients with oesophageal cancer.
    van Heijl M; Phoa SS; van Berge Henegouwen MI; Omloo JM; Mearadji BM; Sloof GW; Bossuyt PM; Hulshof MC; Richel DJ; Bergman JJ; Ten Kate FJ; Stoker J; van Lanschot JJ
    Eur J Surg Oncol; 2011 Dec; 37(12):1064-71. PubMed ID: 21944048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
    Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
    Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.
    Tan BH; Brammer K; Randhawa N; Welch NT; Parsons SL; James EJ; Catton JA
    Eur J Surg Oncol; 2015 Mar; 41(3):333-8. PubMed ID: 25498359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
    Rankin SC; Taylor H; Cook GJ; Mason R
    Clin Radiol; 1998 Sep; 53(9):659-65. PubMed ID: 9766719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.